Consulta Cardiac Resynchronization Pacemaker (CRT-P)
The Medtronic Consulta® CRT-P system is designed specifically for patients who are candidates for cardiac resynchronization therapy and indicated for a bradycardia pacemaker.
How It Works
Consulta® CRT-P combines industry-leading pacing technology, cardiac resynchronization therapy, and Medtronic exclusive features for proactive heart failure management.
- Exclusive OptiVol Fluid Status Monitoring
- Five pacing vectors
- Ensure CRT with exclusive Complete Capture Management
- Convenient follow-up with leadless ECG and Medtronic CareLink® Network
Important Safety Information
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features.
| Medtronic Exclusives | |||||
|---|---|---|---|---|---|
| Exclusive | Exclusive | Exclusive | |||
| OptiVol Monitoring | 5 Pacing Vectors | Complete Capture Management | Leadless ECG | CareLink Network | |
| Consulta® CRT-P Pacemaker | • | • | • | • | • |
OptiVol Fluid Status Monitoring
Consulta CRT-P is the only pacemaker to have OptiVol Fluid Status Monitoring which
- Uses intrathoracic impedance to indicate fluid status in heart failure patients, in the same way as the OptiVol feature in Medtronic ICD and CRT-D devices
OptiVol Fluid Status Monitoring uses intrathoracic impedance measurements
- Has been clinically proven to identify patients at risk for worsening heart failure in more than 2,500 ICD and CRT-D patients1-7
- CRT-P and CRT-D patients share many of the same heart failure characteristics and both groups can benefit from fluid status monitoring
- OptiVol Fluid Status Monitoring is not intended to replace assessments that are part of standard clinical practice
Detail - Chart illustrating how OptiVol helps identify patients at risk for worsening heart failure
References
- Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. August 9, 2005; 112(6):841-848.
- Vollmann D, Nägele H, Schauert P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. August 2007; 28(15):1835-1840.
- Catanzariti D, Lunati M, Landolina M, et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. PACE. March 2008; 32(3):363-370.
- Perego GB, Landolina M, Vergara G, et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. J Interv Card Electrophysiol. December 2008; 23(3):235-242.
- Small RS, Wickemeyer W, Germany R, et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. August 2009;15(6):475-481.
- Abraham WT. Superior performance of intrathoracic impedance-derived fluid index versus daily weight monitoring in heart failure patients. Results of the Fluid Accumulation Status Trial. Late Breaking Clinical Trials. J Card Fail. Vol. 15 No. 9 2009, p 813.
- Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients with Heart Failure) study. J Am Coll Cardiol. April 27, 2010;55(17):1803-1810.
Pacing Vectors
Pacing vectors provide flexible programming options
Multiple pacing vectors:
- Address phrenic nerve stimulation with programming flexibility
- Help prevent the need to invasively reposition the implanted lead
- Enhance ability to choose the best configuration for threshold optimization
Ensure CRT
Exclusive Complete Capture Management™ ensures capture in all chambers.
- Monitors and adjusts outputs to automatically balance patient safety and device longevity1
- Ventricular Sense Response and Conducted AF Response automatically ensure CRT even during atrial fibrillation
Manage Atrial Fibrillation
Medtronic AT/AF intervention algorithms:
- Address rhythm control
- Atrial Rate Stabilization (ARS)
- Post Mode Switch Overdrive Pacing (PMOP)
- Address rate control
- Conducted AF response
- Provide AT/AF therapy
- AT/AF Antitachycardia Pacing (ATP) Ramp, Burst+, 50Hz in office
- Provide multiple AT/AF diagnostics
Reference
- Crossley GH, Mead H, Kleckner K, et al. Automatic left ventricular capture management. Pacing Clin Electrophysiol. October 2007;30(10): 1190-1200.
Convenient Follow-Up
- Exclusive Leadless ECG Waveform is available for more comfortable and convenient assessment in-office and within remote transmissions on the Medtronic CareLink Network
Medtronic’s Leadless ECG Waveform offers patient comfort and convenience
All patient and clinic data displayed are fictitious and for demonstration purposes only.
- The same in-depth device information that is available in an office visit can be transmitted via the exclusive Medtronic CareLink Network
- Exclusive diagnostic capability includes Detailed EGM viewer* and additional EGM storage
*Available through CareLink Network only
Consulta Cardiac Resynchronization Therapy Pacemaker (CRT-P)
15 cc,* 26 g
57 x 59 x 6 mm
8.1 years** longevity
See the Medtronic Consulta CRT-P Pacemaker Clinician Manual.
*Bores open
**600 ohms; 100% atrial pacing; 100% BiV pacing; A and RV Amp = 2.5 V;
LV Amp = 3.0 V; Pre-EGM Storage ON